• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

R406

CAS No. 841290-81-1

R406 ( —— )

产品货号. M16127 CAS No. 841290-81-1

R406 是一种有效的 Syk 抑制剂,IC50 为 41 nM,强烈抑制 Syk,但不抑制 Lyn,其效力比 Flt3 低 5 倍。阶段1。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥446 有现货
5MG ¥697 有现货
10MG ¥1239 有现货
25MG ¥2697 有现货
50MG ¥4010 有现货
100MG ¥5824 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    R406
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    R406 是一种有效的 Syk 抑制剂,IC50 为 41 nM,强烈抑制 Syk,但不抑制 Lyn,其效力比 Flt3 低 5 倍。阶段1。
  • 产品描述
    R406 is a potent Syk inhibitor with IC50 of 41 nM, strongly inhibits Syk but not Lyn, 5-fold less potent to Flt3. Phase 1.
  • 体外实验
    R406 inhibits adenosine A3 receptor (IC50=0.081 μM), adenosine transporter (IC50=1.84 μM), and monoamine transporter (IC50=2.74 μM).R406 inhibits Huh7 hepatocyte, A549 epithelial, and H1299 lung cancer lines with EC50s of 15.1, 2.9 and 6.3 μM, respectively.R406 inhibits phosphorylation of Syk substrate LAT in mast cells and BLNK/SLP65 in B cells. Western Blot AnalysisCell Line:Cultured human mast cells (CHMC)Concentration:0.016, 0.08, 0.4, 2 μM Incubation Time:40 minutes Result:Inhibited all other kinases tested at 5 to 100 fold less potency than Syk as judged by phosphorylation of target proteins.
  • 体内实验
    R406 (5 and 10 mg/kg) shows efficacy in the amelioration of the Arthus reaction and in reducing clinical symptoms in the collagen antibody-induced arthritis (CAIA) and K/BxN models of rheumatoid arthritis (RA). Immune complex (IC)-mediated inflammation is reduced by inhibition of Fc receptor signaling with R406. Animal Model:Female Balb/c mice (6-8 weeks) with CAIADosage:5 and 10 mg/kg Administration:Administered orally, b.i.d, for 14 days, starting 4 hours after antibody challenge on day 0. Result:Reduced inflammation and swelling, and the arthritis progressed more slowly in treated animals than in vehicle controls.Animal Model:Female C57BL/6 mice with arthritis Dosage:10 mg/kg Administration:Administered orally one hour before serum injection; b.i.d; for 13 days Result:Delayed the onset and reduced the severity of clinical arthritis. Paw thickening and clinical arthritis were reduced by approximately 50%.
  • 同义词
    ——
  • 通路
    Angiogenesis
  • 靶点
    Syk
  • 受体
    Syk
  • 研究领域
    Cancer
  • 适应症
    ——

化学信息

  • CAS Number
    841290-81-1
  • 分子量
    628.63
  • 分子式
    C22H23FN6O5·C6H6O3S
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO:126 mg/mL (200.43 mM); Ethanol:8 mg/mL (12.72 mM); Water:<1 mg/mL (<1 mM)
  • SMILES
    OS(=O)(=O)C1=CC=CC=C1.COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4)C=C3)=N2)=CC(OC)=C1OC
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Braselmann S, et al. J Pharmacol Exp Ther, 2006, 319(3), 998-1008.
产品手册
关联产品
  • TAK-659

    TAK-659(TAK659,Mivavotinib)是一种有效的、选择性的、口服的 SYK 抑制剂,IC50 为 3.2 nM。

  • TAK-659 hydrochlorid...

    TAK-659 盐酸盐(Mivavotinib,TAK659)是一种有效的、选择性的、口服的 SYK 抑制剂,IC50 为 3.2 nM。

  • BAY 61-3606 dihydroc...

    一种有效的、ATP 竞争性的、可逆的、高选择性的 Syk 酪氨酸激酶抑制剂,Ki 为 7.5 nM。